LY3537031 Clinical Trials
5 recruitingDrug
Phase 32Phase 22Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company1,100 enrolled123 locationsNCT07219966
Recruiting
Phase 3
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company1,100 enrolled119 locationsNCT07219953
Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
DiarrheaIrritable Bowel Syndrome
Eli Lilly and Company531 enrolled88 locationsNCT07545759
Recruiting
Phase 2
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
ConstipationIrritable Bowel Syndrome
Eli Lilly and Company342 enrolled1 locationNCT07545772
Recruiting
Phase 1
A Study of the Pharmacokinetics and Safety of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment
HealthyHepatic Insufficiency
Eli Lilly and Company32 enrolled3 locationsNCT07165002